Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease
- PMID: 1692847
- PMCID: PMC502358
- DOI: 10.1136/jcp.43.4.298
Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease
Abstract
To determine the intrahepatic production of tumour necrosis factor alpha (TNF alpha) in chronic liver disease three monoclonal antibodies were used against TNF alpha in immunohistochemical studies of liver tissue sections from patients with chronic liver disease. All three monoclonal antibodies stained infiltrating mononuclear cells. Monoclonal antibody II 7C2 also stained the cytoplasm or nucleus, or both, of a varied number of hepatocytes from nine patients with chronic hepatitis B virus infection, suggesting that the antigenic epitope related to hepatitis B core antigen (HBcAg) crossreacted with II7C2. The other two monoclonal antibodies, III2F3 and IV3E5, stained significantly larger numbers of mononuclear cells in cases of chronic active hepatitis B than in chronic persistent hepatitis B, or hepatitis B related liver cirrhosis. III2F3 stained significantly larger numbers of mononuclear cells in non-A, non-B chronic active hepatitis than in chronic persistent hepatitis B or hepatitis B related liver cirrhosis. These results indicate that TNF alpha is produced and secreted by infiltrating mononuclear cells in focal inflammatory areas of the liver, and suggest that TNF alpha may have a role in the inflammatory activity of chronic liver disease.
Similar articles
-
Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis.J Exp Med. 1994 Mar 1;179(3):841-8. doi: 10.1084/jem.179.3.841. J Exp Med. 1994. PMID: 7509363 Free PMC article.
-
Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection.Am J Gastroenterol. 1996 Apr;91(4):748-53. Am J Gastroenterol. 1996. PMID: 8677942
-
Interferon alpha and gamma positive mononuclear cells and HLA antigen expression on hepatocyte membrane in the liver in chronic type B and non-A, non-B hepatitis.Gastroenterol Jpn. 1989 Jun;24(3):255-61. doi: 10.1007/BF02774322. Gastroenterol Jpn. 1989. PMID: 2501137
-
Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management.Expert Opin Biol Ther. 2012 Feb;12(2):193-207. doi: 10.1517/14712598.2012.646986. Epub 2011 Dec 22. Expert Opin Biol Ther. 2012. PMID: 22188392 Review.
-
Interaction of alcohol and hepatitis viral proteins: implication in synergistic effect of alcohol drinking and viral hepatitis on liver injury.Alcohol. 2002 May;27(1):69-72. doi: 10.1016/s0741-8329(02)00201-x. Alcohol. 2002. PMID: 12062640 Review.
Cited by
-
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.Ann Rheum Dis. 2004 Nov;63 Suppl 2(Suppl 2):ii18-ii24. doi: 10.1136/ard.2004.028209. Ann Rheum Dis. 2004. PMID: 15479865 Free PMC article. Review.
-
Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferon.Dig Dis Sci. 1995 Nov;40(11):2423-30. doi: 10.1007/BF02063248. Dig Dis Sci. 1995. PMID: 7587825
-
Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection.J Clin Pathol. 1994 Dec;47(12):1112-5. doi: 10.1136/jcp.47.12.1112. J Clin Pathol. 1994. PMID: 7876386 Free PMC article.
-
Modulation of signaling pathways by RNA virus capsid proteins.Cell Signal. 2008 Jul;20(7):1227-36. doi: 10.1016/j.cellsig.2007.12.018. Epub 2008 Jan 4. Cell Signal. 2008. PMID: 18258415 Free PMC article. Review.
-
Increased tumour necrosis factor alpha production by neutrophils in patients with hepatitis B.J Clin Pathol. 1994 Jul;47(7):616-8. doi: 10.1136/jcp.47.7.616. J Clin Pathol. 1994. PMID: 8089217 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical